SU2C – Nina Nicolai Pancreatic Cancer Innovation in Collaboration Award supports SU2C researchers in collaborative research to accelerate the development of new pancreatic cancer treatments.
Funder: Stand Up To Cancer
Due Dates: Open application (no deadline listed)
Funding Amounts: Award amount and duration not specified
Summary: Supports innovative collaborations within the SU2C scientific community to accelerate the development of new pancreatic cancer treatments.
Key Information: Open only to members of the SU2C scientific community.
The SU2C Nina Nicolai Pancreatic Cancer Innovation in Collaboration Award supports members of the Stand Up To Cancer scientific community in exploring synergistic and innovative collaborations. Its focus is accelerating the development of new treatments for pancreatic cancer, consistent with SU2C’s mission to fund research that addresses critical problems in patient care and delivers near-term patient benefits.
The award sits within SU2C’s broader commitment to novel, collaborative, high-impact cancer research. Its approach emphasizes collaboration over competition, information sharing within research teams, and goal-oriented projects with defined milestones and deliverables. Health equity is a shared priority in both project goals and team makeup, including broader participation by historically underrepresented and underserved populations in biomedical research and clinical trials.